Guillermo Amescua, MD
Ophthalmology · Miami, FLNPI 1376734095
Payments from drug & device makers
Across 121 payments — averaging $7954.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$908K
- W. L. Gore & Associates, Inc.$31K
- Bausch & Lomb Americas Inc.$8K
- Oyster Point Pharma, Inc.$5K
- Carl Zeiss Meditec, Inc.$4K
- Dompe Farmaceutici S.p.a.$4K
- plus $3K from 17 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 16 | $907,995 |
| W. L. Gore & Associates, Inc. | 26 | $31,010 |
| Bausch & Lomb Americas Inc. | 21 | $8,106 |
| Oyster Point Pharma, Inc. | 2 | $4,537 |
| Carl Zeiss Meditec, Inc. | 2 | $4,400 |
| Dompe Farmaceutici S.p.a. | 2 | $3,752 |
| Biotissue Holdings Inc. | 11 | $423 |
| Johnson & Johnson Surgical Vision, Inc. | 5 | $364 |
| Carl Zeiss Meditec USA, Inc. | 3 | $338 |
| Mallinckrodt Hospital Products Inc. | 12 | $311 |
| Alcon | 3 | $301 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $201 |
| Novartis | 2 | $146 |
| Rxsight Inc | 1 | $128 |
| Dompe US, Inc. | 1 | $111 |
| Carl Zeiss Meditec Cataract Technology Inc. | 1 | $110 |
| Sun Pharmaceutical Industries Inc. | 5 | $85 |
| Tarsus Pharmaceuticals, Inc. | 1 | $28 |
| Baudax Bio Inc. | 1 | $23 |
| Harrow Eye, LLC | 1 | $23 |
| Santen Inc. | 1 | $21 |
| Mallinckrodt Enterprises LLC | 1 | $20 |
| Recordati_rare_diseases_inc. | 1 | $17 |
How this compares
$962,452 in reported general payments places this provider in the 95th percentile of 1,405 ophthalmology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Miami
- Felipe MedeirosMiami$935K
- Jennifer LohMiami$606K
- Jaclyn KovachMiami$590K
- William TrattlerMiami$580K
- Wilfredo LaraMiami$526K
- Jayanth SridharMiami$525K
- Kendall DonaldsonMiami$351K
- David EichenbaumSt Petersburg$34.4M
- Robert RadenDelray Beach$7.8M
- Carl DanzigPompano Beach$5.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.